Use of biomolecular targets in the treatment and visualization of tumors
CA 2469480 A1 · Owner: Gonzalez-Zulueta, Mirella · Inventors: Gonzalez-Zulueta, Mirella; Foehr, Erik; Chin, Daniel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the use of a protein that is differentially expressed in primary brain tumor tissues as compared to normal brain tissues, as a biomolecular target for tumor treatment therapies. The protein is also expressed in tissues from adenocarcinoma non-melanoma, and renal carcinoma , cells. Immunotherapeutic and immunoimaging agents that specifically bind to an identified brain tumor target protein are provided. The present invention also provides compounds and pharmaceutically acceptable compositions for administration in the methods of the invention.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 23, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 23, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 23, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.